HMOX1 and posterior cortical atrophy: Interestingly, a very recent work by Wegiel [42] showed a detailed analysis of a large cohort of PCa patients, confirming an enzymatically inactive form of HO-1 in the nuclei of cells and therefore a possible key regulator of cancer progression.